Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
4(31%)
Results Posted
33%(2 trials)
Terminated
2(15%)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_4
10
77%
Ph phase_3
2
15%

Phase Distribution

0

Early Stage

0

Mid Stage

12

Late Stage

Phase Distribution13 total trials
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
10(76.9%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Recruiting4
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (15.4%)
Phase 410 (76.9%)
N/A1 (7.7%)

Trials by Status

recruiting431%
terminated215%
completed646%
unknown18%

Recent Activity

4 active trials
Showing 5 of 13
recruitingphase_3

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

NCT07326540
recruitingnot_applicable

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

NCT06336213
recruitingphase_4

Therapeutic Options for CRAB

NCT06440304
recruitingphase_4

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

NCT05922124
unknownphase_3

Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections

NCT06048692
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07326540Phase 3

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Recruiting
NCT06336213Not Applicable

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

Recruiting
NCT06440304Phase 4

Therapeutic Options for CRAB

Recruiting
NCT05922124Phase 4

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Recruiting
NCT06048692Phase 3

Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections

Unknown
NCT03560232Phase 4

Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens

Terminated
NCT01888822Phase 4

Antibiotic Prophylaxis in Laparoscopic Cholecystectomy

Terminated
NCT00356148Phase 4

The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.

Completed
NCT00368537Phase 4

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Completed
NCT00630513Phase 4

T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam

Completed
NCT00952796Phase 4

A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

Completed
NCT00137007Phase 4

Zithromax EV in Community-Acquired Pneumonia (CAP)

Completed
NCT01138852Phase 4

Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13